Healthcare marketing Q&A · ICG Editorial

Can pharma companies run Google Ads for medicines in India?

Pharma companies cannot run Google Ads that promote prescription-only medicines to the public in India. Indian law directs prescription-drug promotion to registered medical practitioners, and Google's Healthcare and medicines policy restricts prescription-drug ads to a short list of countries and certified advertisers. Pharma companies can still use Google Ads for permitted over-the-counter products, the corporate brand, recruitment, distributor enquiries and carefully worded disease-awareness content.

What are ads in pharma?

Pharma ads are any promotional communication about a company's medicines or brand. In India they split into two worlds: promotion of prescription medicines to doctors and other healthcare professionals, governed by UCPMP 2024, and advertising of permitted over-the-counter products and corporate brands to the public, governed by drug law, the ASCI code and platform policies.

Type of pharma ad	Audience	Main rules
Prescription brand promotion (detailing aids, e-detailing, journal ads)	Registered medical practitioners, healthcare professionals	UCPMP 2024, Drugs and Cosmetics Rules, 1945
OTC product advertising	Consumers	Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, ASCI code, platform policies
Disease-awareness campaigns	Public	Must not become disguised promotion of a prescription brand
Corporate and employer branding	Public, investors, job seekers	General advertising law, ASCI code

The Department of Pharmaceuticals publishes the Uniform Code for Pharmaceutical Marketing Practices, 2024 (UCPMP 2024), which sets the rules for promoting medicines to healthcare professionals.

What does Google Ads' healthcare policy say about prescription drugs?

Google's Healthcare and medicines policy treats prescription drugs as a restricted category. Ads that promote prescription medicines are allowed only in a limited set of countries and only for advertisers Google has certified. As we read the policy in October 2026, India is not a country where manufacturers can promote prescription medicines to the public.

Google also restricts keywords and ad text that mention prescription drug names, unapproved substances and some sensitive health conditions. Even an ad for a permitted product can be limited or disapproved if the landing page names a prescription brand. Google updates the policy and its country lists from time to time, so check the current version before planning a campaign and confirm your approach with regulatory counsel.

Prescription drug services in Google Ads

"Prescription drug services" covers online pharmacies, telehealth that prescribes, and similar services. Google requires certification for these in the countries where it allows them, and the certification rules are country-specific. A pharma manufacturer cannot use a pharmacy or telehealth certification route to promote its own prescription brand to patients.

What can pharma companies advertise on Google in India?

Pharma companies can advertise permitted OTC and wellness products, the corporate brand, careers, distributor and franchise enquiries, B2B and contract-manufacturing services, and unbranded disease-awareness content that steers people to see a doctor. Each needs factual copy and a landing page that does not promote a prescription brand.

OTC products: search and YouTube ads, within what Indian law allows the product to claim.
Corporate brand: brand-name search, reputation and investor pages.
Recruitment: medical representative and plant roles.
Distribution and B2B: stockist, PCD franchise and third-party manufacturing enquiries.
Disease awareness: unbranded education that ends with "consult your doctor", never with a brand.

Our pharma marketing service builds these campaigns with the regulatory review built in. For the full doctor-facing side, see digital marketing for the pharmaceutical industry.

How do pharma companies reach doctors if Google Ads is limited?

Pharma companies reach doctors through channels built for healthcare professionals: medical representatives with e-detailing, verified HCP portals and webinars, medical-journal content, CME support within UCPMP limits, LinkedIn, and opted-in email and WhatsApp communication. Google search and YouTube still help by making scientific and corporate content easy to find.

Build an HCP content hub with gated access for verified professionals.
Equip medical representatives with approved digital detailing material.
Use SEO for corporate, molecule-education and therapy-area pages that do not promote brands to the public. See SEO for pharma companies.
Keep every claim evidence-based and traceable to approved prescribing information, as UCPMP 2024 expects.

How should a pharma company plan a compliant Google Ads account?

Separate campaigns by purpose, so OTC, corporate, recruitment and distribution enquiries each have their own keywords, ads and landing pages. Keep a negative keyword list of prescription brand and molecule names. Have medical and regulatory teams approve ad copy and landing pages before launch, and recheck them whenever Google updates its policy.

One landing page per purpose, with no links to prescription brand pages.
A shared list of approved claims for copywriters.
A monthly check of disapprovals and policy notices in the account.

What gets pharma Google Ads disapproved?

Common triggers are a prescription brand or molecule name in the ad or landing page, disease claims the product cannot legally make, cure or guarantee language, before/after imagery and destination pages that sell medicines without the right certification. Fixing the landing page often matters as much as fixing the ad.

ICG has worked only in healthcare since 2018, with 150+ healthcare and life-sciences brands. Pharma retainers start from ₹20,000 per month and are custom-scoped. This page describes rules at a high level as of October 2026 and is not legal advice.

Detailed answers

No, not to the public. Indian rules direct prescription-medicine promotion to registered medical practitioners, and Google's Healthcare and medicines policy restricts prescription-drug ads to a limited list of countries and certified advertisers. As of October 2026, check Google's current policy and confirm your plan with regulatory counsel.

Generally yes, for products that can legally be advertised to consumers, with factual claims and compliant landing pages. The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and the ASCI code limit what the copy can say, and Google may still restrict ads that mention certain health conditions.

Unbranded awareness that educates people and encourages them to see a doctor is a common approach. It must not become disguised promotion of a prescription brand, for example by naming the molecule, linking to a brand page or using the brand's colours and slogans. Have regulatory counsel review each campaign.

Google checks the ad, the keywords and the landing page. A prescription brand name on the landing page, a restricted health claim, cure or guarantee wording, or an online shop selling medicines without certification can each trigger disapproval. Clean landing pages and factual copy fix most cases.

Yes, for permitted uses such as OTC products, corporate brand, recruitment, distribution enquiries and disease awareness, with copy checked against UCPMP 2024, drug-advertising law and Google's policies. ICG has worked only in healthcare since 2018, and pharma retainers start from ₹20,000 per month.

Google Ads not producing?

Book a free Google Ads account audit.

Raman Soni's team pulls your account, reviews campaign structure, keyword intent tiering, landing pages, and CPQL attribution. 45 minutes, actionable.

Book Google Ads audit → See ICG's pharma marketing service → WhatsApp ICG →